Not for distribution to U.S. Newswire Services or for dissemination in the United States.
Indiva Obtains DTC Eligibility for Common Shares on OTCQX
Indiva makes it easier for shareholders to trade common shares in U.S.
LONDON, Ontario – September 3, 2019: Indiva Limited (the “Company” or “Indiva”) (TSXV:NDVA) (OTCQX:NDVAF) is pleased to announce that it has obtained eligibility with the Depository Trust Company (DTC) for its common shares listed on the OTCQX. DTC is a stock depository that facilitates and simplifies electronic trading of securities in the United States.
Indiva’s common shares, listed on the OTCQX under NDVAF, are now eligible for electronic clearing and settlement through DTC’s automated processes. This electronic method of clearing securities speeds up the receipt of stock and cash, and accelerates the settlement process for certain investors. DTC services also provide cost benefits for investors and brokers trading Canadian securities in the United States.
“This is a significant step forward to increase trading volume and liquidity for Indiva’s common shares in the United States,” Niel Marotta, Indiva’s President and Chief Executive Officer, said.
DTC, a subsidiary of the Depository Trust and Clearing Corporation (DTCC), is a member of the United States’ Federal Reserve System and a registered clearing agency with the Securities and Exchange Commission.
About Indiva
Indiva’s global family of cannabis brands set the standard for quality and innovation. Indiva aims to bring its exceptional portfolio of products to Canadians and cannabis enthusiasts around the world as laws permit. Indiva’s production facility, based in London, Ontario, includes aeroponic, environmentally-conscious grow rooms and a nearly completed extraction and manufacturing space, which will be able to process 70 tonnes of biomass annually and produce safe, high-quality cannabis-infused edibles. In Canada, Indiva will produce and distribute Ruby Cannabis Sugar™, Sapphire Salt™, Ruby Gems™, as well as the award-winning Bhang Chocolate™, and other derivative products through licence agreements and joint ventures. Click here to connect with INDIVA on social media and here to find more information on the Company and its products.
MEDIA CONTACT
Kate Abernathy
Vice President of Communications
Phone: 613-296-5764
Email: [email protected]
INVESTOR CONTACT
Steve Low
Investor Relations
Phone: 647-620-5101
Email: [email protected]
DISCLAIMER & READER ADVISORY
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) has in any way passed upon the merits of the Transaction and neither of the foregoing entities accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this press release.
Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the parties’ current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to the impact of DTC eligibility on the trading volume and liquidity of the Company’s common shares, the Company’s future product offerings and compliance with applicable regulations. Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information. Those assumptions and factors are based on information currently available to the parties. The material factors and assumptions include the parties being able to obtain the necessary regulatory and other third parties’ approvals and licensing and other risks associated with regulated entities in the cannabis industry. The forward-looking information contained in this release is made as of the date hereof and the parties are not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward looking information. The foregoing statements expressly qualify any forward-looking information contained herein.
This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.